Poltreg S.A. (PTG.WA)

PLN 40.0

(-7.83%)

Operating Income Summary of Poltreg S.A.

  • Poltreg S.A.'s latest annual operating income in 2023 was -16.86 Million PLN , down -222.29% from previous year.
  • Poltreg S.A.'s latest quarterly operating income in 2024 Q2 was -5.31 Million PLN , down -39.12% from previous quarter.
  • Poltreg S.A. reported an annual operating income of -5.23 Million PLN in 2022, down -50.34% from previous year.
  • Poltreg S.A. reported an annual operating income of -3.48 Million PLN in 2021, down -264.4% from previous year.
  • Poltreg S.A. reported a quarterly operating income of -5.31 Million PLN for 2024 Q2, down -39.12% from previous quarter.
  • Poltreg S.A. reported a quarterly operating income of -4.36 Million PLN for 2023 Q2, down -102.65% from previous quarter.

Annual Operating Income Chart of Poltreg S.A. (2023 - 2018)

Historical Annual Operating Income of Poltreg S.A. (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -16.86 Million PLN -222.29%
2022 -5.23 Million PLN -50.34%
2021 -3.48 Million PLN -264.4%
2020 -955 Thousand PLN -40.44%
2019 -680 Thousand PLN 46.03%
2018 -1.26 Million PLN 0.0%

Peer Operating Income Comparison of Poltreg S.A.

Name Operating Income Operating Income Difference
Bioceltix S.A. -15.81 Million PLN -6.59%
BIOTON S.A. 15.29 Million PLN 210.245%
Captor Therapeutics Spolka Akcyjna -73.01 Million PLN 76.906%
Mabion S.A. 55.06 Million PLN 130.624%
Molecure S.A. -22.1 Million PLN 23.714%
NanoGroup S.A. -7.9 Million PLN -113.392%
Pharmena S.A. 34.87 Million PLN 148.355%
Pure Biologics Spólka Akcyjna -31.71 Million PLN 46.838%
Ryvu Therapeutics S.A. -100.94 Million PLN 83.296%
Synthaverse S.A. 8.64 Million PLN 295.004%
Urteste S.A. -6.44 Million PLN -161.548%